Nasdaq, S&P 500 reach all-time highs as Big Tech rallies >>> READ MORE


Amgen, Inc. (AMGN) Q4 Earnings Preview

Amgen (AMGN) reports Q4 earnings on Thursday, and if something does weigh on AMGN stock, it'll likely be one of these three factors. More 

Amgen, Inc.: Capture Stronger Upside in AMGN Stock

Uncertainty, optimism and good liquidity are good reasons to consider an Amgen spread in lieu of AMGN stock in front of earnings. More 

Amgen, Inc. (AMGN) Stock Is a Bet on Fatter Yields

Amgen is a company with very fat margins and a growing dividend -- so you can buy AMGN stock today for tomorrow's yield. More 

Why the Amgen, Inc. (AMGN) Patent Case Is So Important

Amgen (AMGN) is pursuing a court case that will force the legal system to make a decision that will essentially become statute. More 

Pfizer Inc. (PFE), Lockheed Martin (LMT) Get “Trumped”

Pfizer (PFE) and Lockheed Martin (LMT) were among the stocks that were rattled Wednesday during Donald Trump's press conference. More 

Should You Buy Amgen Inc. (AMGN) Stock? 3 Pros, 3 Cons

AMGN stock has started 2017 with solid gains. But has Repatha gotten Amgen stock back on track, or will biotech weakness rear its head again? More 

SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!

Biotech stocks have gained the wind, but the SPDR S&P Biotech (ETF) (XBI) hasn't yet caught up with the market. That's going to change soon. More